These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10376646)

  • 1. QT lengthening and arrhythmias associated with fexofenadine.
    Giraud T
    Lancet; 1999 Jun; 353(9169):2072-3. PubMed ID: 10376646
    [No Abstract]   [Full Text] [Related]  

  • 2. QT lengthening and life-threatening arrhythmias associated with fexofenadine.
    Craig-McFeely PM; Freemantle SL; Pearce GL; Shakir SA
    Br J Gen Pract; 2000 Feb; 50(451):148. PubMed ID: 10750216
    [No Abstract]   [Full Text] [Related]  

  • 3. QT lengthening and life-threatening arrhythmias associated with fexofenadine.
    Pinto YM; van Gelder IC; Heeringa M; Crijns HJ
    Lancet; 1999 Mar; 353(9157):980. PubMed ID: 10459910
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drug side effects and their prevention].
    Hautarzt; 1997 Aug; 48(8 Suppl):3-4. PubMed ID: 9378645
    [No Abstract]   [Full Text] [Related]  

  • 5. Prolonged QTc time and ventricular arrhythmia with fexofenadine.
    Kashyap AS; Kashyap S
    Am J Cardiol; 1999 Nov; 84(10):1278-9. PubMed ID: 10569349
    [No Abstract]   [Full Text] [Related]  

  • 6. Is my antihistamine safe?
    Ashworth L
    Home Care Provid; 1997 Jun; 2(3):117-20. PubMed ID: 9274181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of electropharmacological effects between terfenadine and its active derivative fexofenadine using a cross-over study in halothane-anesthetized dogs to analyze variability of pharmacodynamic and pharmacokinetic profiles of terfenadine and torsadogenic risk of fexofenadine.
    Ando K; Nakamura Y; Hagiwara-Nagasawa M; Harada H; Miyamoto H; Inamura N; Takagi K; Goto A; Chiba K; Lubna NJ; Izumi-Nakaseko H; Naito AT; Sugiyama A
    J Toxicol Sci; 2018; 43(3):183-192. PubMed ID: 29540652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fexofenadine: new preparation. Terfenadine, without cardiotoxicity.
    Prescrire Int; 1999 Feb; 8(39):11-3. PubMed ID: 10557567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics, pharmacodynamics, and tolerance of single- and multiple-dose fexofenadine hydrochloride in healthy male volunteers.
    Russell T; Stoltz M; Weir S
    Clin Pharmacol Ther; 1998 Dec; 64(6):612-21. PubMed ID: 9871426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fexofenadine and prolonged QT intervals.
    Shuster J
    Nursing; 1999 Sep; 29(9):72. PubMed ID: 10540625
    [No Abstract]   [Full Text] [Related]  

  • 11. Terfenadine-associated ventricular arrhythmias and QTc interval prolongation. A retrospective cohort comparison with other antihistamines among members of a health maintenance organization.
    Hanrahan JP; Choo PW; Carlson W; Greineder D; Faich GA; Platt R
    Ann Epidemiol; 1995 May; 5(3):201-9. PubMed ID: 7606309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prolongation of the Q-T interval and hyperkinetic ventricular arrhythmias probably induced by terfenadine use in liver cirrhosis patients].
    Venturini E; Borghi E; Maurini V; Vecce R; Carnicelli A
    Recenti Prog Med; 1992 Jan; 83(1):21-2. PubMed ID: 1561478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Causality assessment of adverse drug effects: when is rechallenge ethically acceptable?
    Po AL; Kendall MJ
    Lancet; 1999 Aug; 354(9179):683. PubMed ID: 10466699
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and safety of fexofenadine hydrochloride for treatment of seasonal allergic rhinitis.
    Bernstein DI; Schoenwetter WF; Nathan RA; Storms W; Ahlbrandt R; Mason J
    Ann Allergy Asthma Immunol; 1997 Nov; 79(5):443-8. PubMed ID: 9396979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe cardiac arrhythmia on fexofenadine?
    Prescrire Int; 2000 Feb; 9(45):212. PubMed ID: 11503802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Terfenadine use associated with ventricular dysrhythmias.
    Krasner LM
    Crit Care Nurse; 1992 Feb; 12(2):51-2. PubMed ID: 1544306
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug interactions associated with terfenadine and related nonsedating antihistamines.
    Zechnich AD; Haxby DG
    West J Med; 1996 Jan; 164(1):68-9. PubMed ID: 8779212
    [No Abstract]   [Full Text] [Related]  

  • 18. Fexofenadine-induced QT prolongation: a myth or fact?
    Dhar S; Hazra PK; Malakar S; Mistri G
    Br J Dermatol; 2000 Jun; 142(6):1260-1. PubMed ID: 10848773
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug-induced QRS morphology and duration changes.
    Madias JE
    Cardiol J; 2008; 15(6):505-9. PubMed ID: 19039753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fexofenadine's effects, alone and with alcohol, on actual driving and psychomotor performance.
    Vermeeren A; O'Hanlon JF
    J Allergy Clin Immunol; 1998 Mar; 101(3):306-11. PubMed ID: 9525444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.